PET CT Siemens supplied Neuro VPCT ASplus

August 27, 2012 — The growth rate of positron emission tomography (PET) and PET/computed tomography (CT) medical imaging scans in the United States began to slow in 2011, with an estimated 1.85 million clinical PET patient exams performed in 2011, down from a double-digit growth rate reported in previous years, according to a new market research report by IMV Medical Information Division.

“The estimated 1.85 million clinical PET patient studies performed in 2011 represent a 6 percent increase over IMV’s estimate of 1.74 million patient studies performed in 2010,” observed Lorna Young, senior director, market research at IMV. “This represents a continued slowing in the annual growth rate for PET patient studies."

The current numbers compare to annual growth from 2008 to 2010 of about 7 percent, and to annual growth between 2005 and 2008 of 10 percent. Young noted that in 2011, most of the growth was from an increase in the number of sites providing PET services; the average procedure increase per site was only 0.6 percent when compared to 2010. These PET studies were performed in 2,210 hospital and nonhospital sites, using fixed or mobile PET/CT or PET scanners.

Oncology continues to drive the use of PET imaging procedures, as hospitals open cancer treatment centers and install PET/CT scanners to support their oncology services. The study found that about 94 percent of all PET studies in 2012 were for cancer, distributed between diagnosis (19 percent), staging (38 percent), treatment planning (13 percent) and followup (30 percent). Neurology and cardiology applications make up the remaining 6 percent of procedures, divided evenly between the two.

Used for 96 percent of all PET procedures in 2011, fluorine-18 fluorodeoxyglucose (FDG) is still the mainstay of PET imaging. Rubidium-82, the next most frequently used radiopharmaceutical, was used for about 2 percent of all procedures, as problems with the supply of the radiopharmaceutical continued to limit its use for cardiac perfusion studies.

The report describes trends in PET and PET/CT patient exams by procedure type, PET and PET/CT installed base by manufacturer and year of installation, planned purchases and market scenarios for unit scanner sales through 2016, radiopharmaceutical utilization and expenditures by supplier, and site operations characteristics.

Other report highlights include:
• 44 percent of all PET imaging studies were performed using a mobile PET or mobile PET/CT scanner.
• 14 percent of all PET and PET/CT users plan on purchasing a new system in the next three years.
• 95 percent of PET patient studies used radiopharmaceuticals purchased from an outside supplier, and 5 percent were obtained from cyclotrons on site.
• The top four cancer types imaged with PET are respiratory, lymphoma, breast and colorectal.
• The five states with the highest PET patient study volume are California, Florida, New York, Texas and Pennsylvania.

IMV’s 2012 PET & PET/CT Census Database provides comprehensive profiles of the identified PET imaging sites in the United States. The database can be licensed by qualified subscribers and includes contact and site-specific information. IMV's 2012 PET Imaging Market Summary Report is available with the database license or as a separate purchase.

For more information, visit http://PETReport.imvinfo.com
 


Related Content

News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
Subscribe Now